首页> 外文期刊>The Lancet >Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
【24h】

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

机译:患有和不患有高血压的个体中肾脏疾病措施与死亡率和终末期肾脏疾病的关联:一项荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background Hypertension is the most prevalent comorbidity in individuals with chronic kidney disease. However, whether the association of the kidney disease measures, estimated glomerular filtration rate (eGFR) and albuminuria, with mortality or end-stage renal disease (ESRD) differs by hypertensive status is unknown.Methods We did a meta-analysis of studies selected according to Chronic Kidney Disease Prognosis Consortium criteria. Data transfer and analyses were done between March, 2011, and June, 2012. We used Cox proportional hazards models to estimate the hazard ratios (HR) of mortality and ESRD associated with eGFR and albuminuria in individuals with and without hypertension.Findings We analysed data for 45 cohorts (25 general population, seven high-risk, and 13 chronic kidney disease) with 1127656 participants, 364344 of whom had hypertension. Low eGFR and high albuminuria were associated with mortality irrespective of hypertensive status in the general population and high-risk cohorts. All-cause mortality risk was 1 " 1-1 " 2 times higher in individuals with hypertension than in those without hypertension at preserved eGFR. A steeper relative risk gradient in individuals without hypertension than in those with hypertension at eGFR range 45-75 mL/min per 1 " 73 m2 led to much the same mortality risk at lower eGFR. With a reference eGFR of 95 mL/min per 1 " 73 m2 in each group to explicitly assess interaction, adjusted HR for all-cause mortality at eGFR 45 mL/min per 1-73 m2 was 1-77 (95% CI 1-57-1-99) in individuals without hypertension versus 1-24 (1-11-1-39) in those with hypertension (p for overall interaction=0003). Similarly, for albumin-creatinine ratio of 300 mg/g (vs 5 mg/g), HR was 2 " 30 (1 . 98-2 " 68) in individuals without hypertension versus 2 " 08 (1 " 84-2 " 35) in those with hypertension (p for overall interaction0. 019). We recorded much the same results for cardiovascular mortality. The associations of eGFR and albuminuria with ESRD, however, did not differ by hypertensive status. Results for chronic kidney disease cohorts were similar to those for general and high-risk population cohorts.
机译:背景高血压是慢性肾脏病患者中最普遍的合并症。然而,根据高血压状况,是否将肾脏疾病的测量指标,估计的肾小球滤过率(eGFR)和白蛋白尿与死亡率或终末期肾脏疾病(ESRD)的相关性是否不同尚不清楚。方法我们对选择的研究进行了荟萃分析符合慢性肾脏病预后联合会标准。在2011年3月至2012年6月之间进行了数据传输和分析。我们使用Cox比例风险模型来估计患有和不患有高血压的人的死亡率和ESRD与eGFR和蛋白尿相关的危险比(HR)。研究对象为45个队列(25个普通人群,7个高危人群和13个慢性肾脏疾病),共有1127656名参与者,其中364344名患有高血压。低eGFR和高蛋白尿与死亡率相关,而与普通人群和高危人群的高血压状态无关。保留eGFR的高血压患者的全因死亡率风险比没有高血压的人高1“ 1-1” 2倍。在eGFR范围为1“ 73 m2时,没有高血压的个体的相对风险梯度比有高血压的患者陡峭,导致更低的eGFR的死亡风险几乎相同。参考eGFR为95 mL / min / 1 “在没有高血压的个体中,每组73平方米用于明确评估相互作用的eHR,每1-73平方米eGFR 45 mL / min的全因死亡率调整后的HR为1-77(95%CI 1-57-1-99)患有高血压的患者为1-24(1-11-1-39)(总体相互作用为p = 0.003)。同样,对于白蛋白-肌酐比为300 mg / g(vs 5 mg / g),无高血压的人的HR为2“ 30(1. 98-2” 68),而2“ 08(1” 84-2“ 35) )(在总体高血压中,p表示整体交互作用。019)。我们记录的心血管疾病死亡率几乎相同,但是eGFR和蛋白尿与ESRD的相关性因高血压状况而无差异。慢性肾脏病队列的结果相似适用于一般人群和高危人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号